Opus Genetics (IRD) Return on Invested Capital (2022)

Opus Genetics' (IRD) quarterly Return on Invested Capital came in at 0.37% in Q4 2022.

Opus Genetics (IRD) Return on Invested Capital (2022) Analysis & Trends

Opus Genetics (IRD) has 1 years of Return on Invested Capital data on file, last reported at 0.37% in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	0.00%
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	0.04%
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Opus Genetics	3.27 Mn	-56.73 Mn	-	-

Download Data

Date	Value
Dec 31, 2022	0.37%